273 related articles for article (PubMed ID: 37360400)
1. Medicinal chemistry approaches to target the MNK-eIF4E axis in cancer.
Fernandez A; Monsen PJ; Platanias LC; Schiltz GE
RSC Med Chem; 2023 Jun; 14(6):1060-1087. PubMed ID: 37360400
[TBL] [Abstract][Full Text] [Related]
2. Mnk2 and Mnk1 are essential for constitutive and inducible phosphorylation of eukaryotic initiation factor 4E but not for cell growth or development.
Ueda T; Watanabe-Fukunaga R; Fukuyama H; Nagata S; Fukunaga R
Mol Cell Biol; 2004 Aug; 24(15):6539-49. PubMed ID: 15254222
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of the mRNA cap-binding protein eIF4E and cancer.
Yang X; Zhong W; Cao R
Cell Signal; 2020 Sep; 73():109689. PubMed ID: 32535199
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Mitogen-activated Protein Kinase (MAPK)-interacting Kinase (MNK) Preferentially Affects Translation of mRNAs Containing Both a 5'-Terminal Cap and Hairpin.
Korneeva NL; Song A; Gram H; Edens MA; Rhoads RE
J Biol Chem; 2016 Feb; 291(7):3455-67. PubMed ID: 26668315
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of mammalian target of rapamycin induces phosphatidylinositol 3-kinase-dependent and Mnk-mediated eukaryotic translation initiation factor 4E phosphorylation.
Wang X; Yue P; Chan CB; Ye K; Ueda T; Watanabe-Fukunaga R; Fukunaga R; Fu H; Khuri FR; Sun SY
Mol Cell Biol; 2007 Nov; 27(21):7405-13. PubMed ID: 17724079
[TBL] [Abstract][Full Text] [Related]
6. The MNK-eIF4E Signaling Axis Contributes to Injury-Induced Nociceptive Plasticity and the Development of Chronic Pain.
Moy JK; Khoutorsky A; Asiedu MN; Black BJ; Kuhn JL; Barragán-Iglesias P; Megat S; Burton MD; Burgos-Vega CC; Melemedjian OK; Boitano S; Vagner J; Gkogkas CG; Pancrazio JJ; Mogil JS; Dussor G; Sonenberg N; Price TJ
J Neurosci; 2017 Aug; 37(31):7481-7499. PubMed ID: 28674170
[TBL] [Abstract][Full Text] [Related]
7. Roles of mitogen-activated protein kinase signal-integrating kinases 1 and 2 in oxidant-mediated eIF4E phosphorylation.
Shenberger JS; Zhang L; Hughlock MK; Ueda T; Watanabe-Fukunaga R; Fukunaga R
Int J Biochem Cell Biol; 2007; 39(10):1828-42. PubMed ID: 17689282
[TBL] [Abstract][Full Text] [Related]
8. Negative regulation of protein translation by mitogen-activated protein kinase-interacting kinases 1 and 2.
Knauf U; Tschopp C; Gram H
Mol Cell Biol; 2001 Aug; 21(16):5500-11. PubMed ID: 11463832
[TBL] [Abstract][Full Text] [Related]
9. Mitogen-activated Protein Kinase (MAPK) Interacting Kinases 1 and 2 (MNK1 and MNK2) as Targets for Cancer Therapy: Recent Progress in the Development of MNK Inhibitors.
Dreas A; Mikulski M; Milik M; Fabritius CH; Brzózka K; Rzymski T
Curr Med Chem; 2017; 24(28):3025-3053. PubMed ID: 28164761
[TBL] [Abstract][Full Text] [Related]
10. Protein phosphatase 2A negatively regulates eukaryotic initiation factor 4E phosphorylation and eIF4F assembly through direct dephosphorylation of Mnk and eIF4E.
Li Y; Yue P; Deng X; Ueda T; Fukunaga R; Khuri FR; Sun SY
Neoplasia; 2010 Oct; 12(10):848-55. PubMed ID: 20927323
[TBL] [Abstract][Full Text] [Related]
11. Progress in developing MNK inhibitors.
Jin X; Yu R; Wang X; Proud CG; Jiang T
Eur J Med Chem; 2021 Jul; 219():113420. PubMed ID: 33892273
[TBL] [Abstract][Full Text] [Related]
12. Regulation of eukaryotic initiation factor 4E (eIF4E) phosphorylation by mitogen-activated protein kinase occurs through modulation of Mnk1-eIF4G interaction.
Shveygert M; Kaiser C; Bradrick SS; Gromeier M
Mol Cell Biol; 2010 Nov; 30(21):5160-7. PubMed ID: 20823271
[TBL] [Abstract][Full Text] [Related]
13. Human eukaryotic translation initiation factor 4G (eIF4G) recruits mnk1 to phosphorylate eIF4E.
Pyronnet S; Imataka H; Gingras AC; Fukunaga R; Hunter T; Sonenberg N
EMBO J; 1999 Jan; 18(1):270-9. PubMed ID: 9878069
[TBL] [Abstract][Full Text] [Related]
14. Small Molecules Targeting the Inactive Form of the Mnk1/2 Kinases.
Kannan S; Pradhan MR; Cherian J; Joseph TL; Poh ZY; Hai Yan Y; Melvyn H; Boping L; Jeffrey H; Nacro K; Verma CS
ACS Omega; 2017 Nov; 2(11):7881-7891. PubMed ID: 30023565
[TBL] [Abstract][Full Text] [Related]
15. The mitogen-activated protein kinase signal-integrating kinase Mnk2 is a eukaryotic initiation factor 4E kinase with high levels of basal activity in mammalian cells.
Scheper GC; Morrice NA; Kleijn M; Proud CG
Mol Cell Biol; 2001 Feb; 21(3):743-54. PubMed ID: 11154262
[TBL] [Abstract][Full Text] [Related]
16. Identification of a Highly Conserved Allosteric Binding Site on Mnk1 and Mnk2.
Basnet SK; Diab S; Schmid R; Yu M; Yang Y; Gillam TA; Teo T; Li P; Peat T; Albrecht H; Wang S
Mol Pharmacol; 2015 Nov; 88(5):935-48. PubMed ID: 26268528
[TBL] [Abstract][Full Text] [Related]
17. Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming.
Geter PA; Ernlund AW; Bakogianni S; Alard A; Arju R; Giashuddin S; Gadi A; Bromberg J; Schneider RJ
Genes Dev; 2017 Nov; 31(22):2235-2249. PubMed ID: 29269484
[TBL] [Abstract][Full Text] [Related]
18. Negative regulatory effects of Mnk kinases in the generation of chemotherapy-induced antileukemic responses.
Altman JK; Glaser H; Sassano A; Joshi S; Ueda T; Watanabe-Fukunaga R; Fukunaga R; Tallman MS; Platanias LC
Mol Pharmacol; 2010 Oct; 78(4):778-84. PubMed ID: 20664001
[TBL] [Abstract][Full Text] [Related]
19. First MNKs degrading agents block phosphorylation of eIF4E, induce apoptosis, inhibit cell growth, migration and invasion in triple negative and Her2-overexpressing breast cancer cell lines.
Ramalingam S; Gediya L; Kwegyir-Afful AK; Ramamurthy VP; Purushottamachar P; Mbatia H; Njar VC
Oncotarget; 2014 Jan; 5(2):530-43. PubMed ID: 24504069
[TBL] [Abstract][Full Text] [Related]
20. Signalling to eIF4E in cancer.
Siddiqui N; Sonenberg N
Biochem Soc Trans; 2015 Oct; 43(5):763-72. PubMed ID: 26517881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
